Clinical trial Duravelo-3
Phase 2 Study of Zelenectide Pevedotin in Participants with NECTIN4 Amplified Advanced Breast Cancer (BT8009-201)
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Bicycle Tx Limited |
| EudraCT Identifier | 2024-517868-33-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT06840483 |
| Last update |